However, in lung tumors, other groups have suggested that PD-1 expressed on tumor cells inhibits their proliferation and that PD-1 blockade enhances tumor growth by activating AKT and ERK1/2 (Du et al., 2018; Wang X. et al., 2020). The gene discussed is AKT1; the disease is neoplasm.